Home > Adults > Endocrinology >

Endocrinology Services - UHBW and NBT

Checked: 08-01-2024 by Vicky Ryan Next Review: 07-01-2026

Service Overview - UHBW

University Hospitals Bristol provide many endocrine services.

The below clinics accept referrals via e-Referral:

Adrenal Disorder
Lipid Disorders
Metabolic Bone Disorders
Pituitary & Hypothalamic
Thyroid/Parathyroid
Joint Thyroid/Eye Clinic
Grave's Disease (Thyroid Eye Disease)

See UHB's Endocrinology webpage for further information regarding the services they offer and how to refer into them.

Service Overview - NBT

North Bristol Trust provide many endocrine services.

The below clinics accept referrals via e-Referral:

Adrenal Disorders
Metabolic Bone Disorders
Pituitary & Hypothalamic
Thyroid / Parathyroid
Gynaecological Endocrinology

See NBT's Endocrinology webpage for further information regarding the services.

Most referrals should be made via e-Referral.

Please note the following regarding appointment at NBT
• All new appointments are 30 minutes long and are available between 8:00am and 9:30am. This is to help facilitate hormone blood tests that may need to be taken early morning. We are sorry that we are unable to offer guaranteed appointments times to patients on request prior to booking.
• We offer face to face, and telephone follow up appointments which are agreed between consultant and patient. These appointments are 20 minutes and are available between 9.30am and 11.10am.

For urgent advice pending review or for existing NBT Endocrine patients, the team can be contacted via the SpR mobile via switch (after 1pm Monday-Friday) or via email: diabetesandendocrinologyadmin@nbt.nhs.uk

Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.